Db/db mice, characterised by mutations in the leptin receptor gene, exhibit a disrupted leptin signalling pathway, resulting in obesity, insulin resistance, hyperglycaemia, lipid metabolism disorders, inflammation, and oxidative stress. This evidence concerns the gene LEP and Hyperglycemia.